Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedDec 3, 2014Leuprolide 50 mcg/0.1 mL Micro Lupron KitLack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control...Perry Drug Inc. · D-0262-2015Class IITerminatedDec 3, 2014Tri-MixLack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control...Perry Drug Inc. · D-0261-2015Class IITerminatedDec 3, 2014Methyl B12 25 mg/mL InjLack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control...Perry Drug Inc. · D-0260-2015Class IITerminatedDec 3, 2014Testosterone CYP-250/PROP-20 mgLack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control...Perry Drug Inc. · D-0259-2015Class IITerminatedDec 3, 2014Diclofenac Sodium and Misoprostol Delayed-Release TabletsFailed Tablet/Capsule Specifications: Presence of split or broken tablets.Actavis Laboratories, FL, Inc. · D-0258-2015Class IIITerminatedDec 3, 2014Amlodipine Besylate TabletsDiscoloration: Brown spots were noted embedded in Amlodipine Besylate Tablets, 10 mg, Lot # MP4344.Zydus Pharmaceuticals USA Inc · D-0257-2015Class IITerminatedDec 3, 2014Potassium Chloride InjectionLabeling: Label Error On Declared Strength: Bags of Potassium Chloride 10 mEq per 100 mL were incorrectly overpouched with wraps labeled as Potassium Chloride Injection...Baxter Healthcare Corp. · D-0256-2015Class IITerminatedNov 26, 2014Tetrahydrozoline HydrochlorideCGMP Deviations; Stored/dispensed in a non-GMP compliant warehouse at S.I.M.S., Italy.Spectrum Laboratory Products · D-0255-2015Class IIITerminatedNov 26, 2014Sterile powder Vancomycin Hydrochloride for InjectionCorrect Labeled Product Mispack: Product tray containing vials was mislabeled to contain another product.Hospira Inc. · D-0254-2015Class IITerminatedNov 26, 2014LOSARTAN POTASSIUM TABLETS USPFailed Content Uniformity Specifications; Dry mix failed blend uniformity.Micro Labs Usa, Inc S · D-0253-2015Class ITerminatedNov 26, 2014Trace Mineral-5 MDVNon-Sterility; contract laboratory identified Staphylococcus warneri in the productAbrams Royal Pharmacy · D-0252-2015Class ITerminatedNov 26, 2014Lidocaine 18.18 mg/mL/Bupivacaine 2.27 mg/mL/Epinephrine 0.0022 mg/mL/Hyaluronidase13.64 u/mLNon-SterilityAbrams Royal Pharmacy · D-0251-2015Class ITerminatedNov 26, 2014Calcium Chloride Preservative Free Sterile injectionNon-Sterility: The firm's contract testing laboratory found sterility failures.Abrams Royal Pharmacy · D-0250-2015Class IITerminatedNov 26, 2014Mercaptopurine TabletsFailed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing.Prometheus Laboratories Inc. · D-0249-2015Class IITerminatedNov 19, 2014Assured Naproxen Sodium TabletsCorrect Labeled Product Mispacked; correct labeled bottles of Assured Ibuprofen softgels were packaged into cartons of Assured Naproxen Sodium Tablets, USPContract Packaging Resources Inc. · D-0248-2015Class IIITerminatedNov 19, 2014HALOPERIDOL DECANOATE INJECTIONFailed Impurities/Degradation Specifications: Fresenius Kabi is recalling three lots of Haloperidol Decanoate Injection due to an out-of-specification result.Fresenius Kabi USA LLC · D-0247-2015Class IIITerminatedNov 19, 2014Simvastatin TabletsFailed Impurities/Degradation Specifications: Product failed Impurity content (Butylated Hydroxy Anisole Content) against shelf life specification.Micro Labs Usa, Inc S · D-0246-2015Class IITerminatedNov 19, 2014FLUOCINONIDE GEL USPFailed Stability Specifications: The lots of Fluocinonide Gel USP, 0.05% recalled, may not meet the requirements for residual solvents as outlined in USP <467>.Fougera Pharmaceuticals Inc. · D-0245-2015Class IIITerminatedNov 12, 2014Candesartan Cilexetil TabletsFailed Impurities/Degradation Specifications: Out of specification (OOS) results were observed for CAD-II, CAD-V and Total Impurities.Apotex Inc. · D-0244-2015Class IIITerminatedNov 12, 2014Candesartan Cilexetil TabletsFailed Impurities/Degradation Specifications: Out of specification (OOS) results were observed for CAD-II, CAD-V and Total Impurities.Apotex Inc. · D-0243-2015Class IIITerminatedNov 12, 2014Candesartan Cilexetil TabletsFailed Impurities/Degradation Specifications: Out of specification (OOS) results were observed for CAD-II, CAD-V and Total Impurities.Apotex Inc. · D-0242-2015Class IIITerminatedNov 12, 2014Candesartan Cilexetil TabletsFailed Impurities/Degradation Specifications: Out of specification (OOS) results were observed for CAD-II, CAD-V and Total Impurities.Apotex Inc. · D-0241-2015Class IITerminatedNov 12, 2014Cyproheptadine HCl SyrupFailed Impurities/Degradation Specifications : Out-of-specification result for an unidentified impurity at the 12 month stability test point.Pharmaceutical Associates Inc · D-0240-2015Class IIITerminatedNov 12, 2014Loratadine 24 HR-OTCFailed Tablet/Capsule Specifications: Affected lot numbers may contain chipped or broken tablets.Physicians Total Care, Inc. · D-0239-2015Class IIITerminatedNov 12, 2014Z-COTE HP 1 TRANSPARENT ZINC OXIDEcGMP Deviation; The incorrect amount of a raw material was added during the manufacture of two lots of Z-COTE HP 1.Nanophase Technologies Corporation · D-0238-2015Class IITerminatedNov 12, 2014CEPHALEXIN MONOHYDRATE CAPSULESCGMP deviations: Products were manufactured with active pharmaceutical ingredients that were not manufactured with good manufacturing practices.Physicians Total Care, Inc. · D-0237-2015Class IITerminatedNov 12, 2014Venlafaxine Hydrochloride Extended-Release TabletsFailed Dissolution Specifications; 12 month stability time pointSun Pharma Global Inc. · D-0236-2015Class IIITerminatedNov 12, 2014TORISEL KitCrystallization: Impurities in a raw material used to manufacture the diluent can cause the formation of crystals in the diluent vials after cold storage. The TORISEL...Pfizer Inc. · D-0235-2015Class IITerminatedNov 12, 2014Obagi Nu-Derm ClearLabeling: Label Mix-Up; Containers of the Obagi Nu-Derm Clear pre-labeled bottles were inadvertently introduced into the Obagi Exfoderm Forte packaging line. Therefore...Obagi Medical Products · D-0234-2015Class IITerminatedNov 12, 2014VITAMIN B COMPLEXLack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that...Oregon Compounding Centers, Inc. dba Creative Compounds · D-0228-2015Class IITerminatedNov 12, 2014VANCOMYCINLack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that...Oregon Compounding Centers, Inc. dba Creative Compounds · D-0227-2015Class IITerminatedNov 12, 2014TRIESENCELack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that...Oregon Compounding Centers, Inc. dba Creative Compounds · D-0226-2015Class IITerminatedNov 12, 2014TOBRAMYCINLack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that...Oregon Compounding Centers, Inc. dba Creative Compounds · D-0225-2015Class IITerminatedNov 12, 2014TESTOSTERONE CYPIONATELack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that...Oregon Compounding Centers, Inc. dba Creative Compounds · D-0224-2015Class IITerminatedNov 12, 2014TESTOSTERONE CYPIONATELack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that...Oregon Compounding Centers, Inc. dba Creative Compounds · D-0223-2015Class IITerminatedNov 12, 2014SODIUM CHLORIDE INHALATIONLack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that...Oregon Compounding Centers, Inc. dba Creative Compounds · D-0222-2015Class IITerminatedNov 12, 2014PYRIDOXINE HCLLack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that...Oregon Compounding Centers, Inc. dba Creative Compounds · D-0221-2015Class IITerminatedNov 12, 2014PROCAINE HCLLack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that...Oregon Compounding Centers, Inc. dba Creative Compounds · D-0220-2015Class IITerminatedNov 12, 2014PREDNISOLONE Sodium PhosphateLack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that...Oregon Compounding Centers, Inc. dba Creative Compounds · D-0219-2015Class IITerminatedNov 12, 2014PAPAVERINE/PHENTOLAMINE/PROSTAGLANDINLack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that...Oregon Compounding Centers, Inc. dba Creative Compounds · D-0218-2015